VelacurTM, the first handheld 3D liver health assessment solution, is coming to the 2021 Annual TSGE Conference, September 24 to 26!
If you care for patients with chronic liver disease (including fatty liver disease) or are interested in building your practice, visit our booth for a live VelacurTM demo and to connect with our team.
Developed by Sonic Incytes Medical Corp, VelacurTM is a new, non-invasive liver imaging test with accuracy comparable to MRI.
For more information about VelacurTM or to book a private demo, visit www.velacur.com.
Follow us on LinkedIn, Twitter, and YouTube, and subscribe to our e-newsletter below.
